ALEXANDRIA, Va., Dec. 31 -- United States Patent no. 12,509,462, issued on Dec. 30, was assigned to BIOVERSYS AG (Basel, Switzerland).

"3-(phenylsulfonyl)-[1,2,3triazolo[1,5Aquinazolin-5(4H)-one derivatives" was invented by Marilyne Bourotte (Perenchies, France), Michel Pieren (Therwil, Switzerland), Sergio Lociuro (Rancate, Switzerland), Marc Gitzinger (Laufenburg, Switzerland), Christian Kemmer (Riehen, Switzerland), Birgit Schellhorn (Weil am Rhein, Germany), Julian Schill (Basel, Switzerland) and Peter Schneider (Bottmingen, Switzerland).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention relates to a compound according to formula (I) wherein R1 to R9 are as described herein; and pharmace...